INSIGHTS ON PHARMACEUTICAL PACKAGING

• Ophthalmic Product Package Inspection

  Microscopic leaks in ophthalmic packaging can compromise sterility and patient safety. Learn how advanced vacuum decay testing delivers fast, reliable results, detecting defects as small as 5 microns.

• Cutting Through Complexity: An Integrated Model For Faster PFS Development

  Discover how integrated, end-to-end development for prefilled syringes can streamline timelines, enhance patient-centric delivery, and scale efficiently from early development to global launch.

• Determining The Limit Of Detection In CCIT

  Accurately determining the smallest detectable defect in pharmaceutical packaging is essential for sterility. Learn how test sensitivity, positive controls, and regulatory standards shape CCI strategies.

• Key Considerations When Choosing A Device For Dry Powder Nasal Delivery

  Building on previous discussions, here we discuss the benefits of nasal delivery and the challenges of developing dry powder formulations by focusing on key devices that can be used for delivering dry powder nasal dosage forms.

• 5 Critical PUPSIT Considerations For Sponsors Targeting The EU Market

  1/22/2026

  To ensure compliance with EU GMP Annex 1 guidelines and drug product approval, familiarize yourself with PUPSIT: how it works, why it’s needed, and strategies to maximize success.

• Rare Diseases And The Integrated CDMO Support System

  4/7/2026

  Champion the rare‑disease community by advancing development models built on precision, continuity and global coordination that ensure every dose reaches the patients who need it most.

• 3D Screen Printing: Enabling A New Generation Of Complex Formulations

  3/17/2025

  Screen-Printed Innovative Drug Technology can produce oral, transdermal, and implantable dosage forms while ensuring heterogeneous distribution of active ingredients.

• Commercializing Innovation

  3/13/2026

  Explore how packaging safeguards life science products and why innovation cultures matter. Oliver Stauffer offers grounded insights on turning scientific advances into sustainable, real-world impact.

• Ensuring Tablet Logo Legibility: A Critical Step In Preventing Medication Errors

  11/11/2024

  Tablet debossing aids medication identification and must meet FDA standards. Font, scale, color, shadow, and stroke details are key for optimal legibility and safety.